| 1. |
Prystowsky EN, Benson DW, Fuster V, et al. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation, 1996, 93(6): 1262-1277.
|
| 2. |
Pappone C, Oral H, Santinelli V, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation, 2004, 109(22): 2724-2726.
|
| 3. |
佘飛, 劉書旺, 郭麗君. 左心耳封堵術在心房顫動患者中的應用價值. 中國心血管雜志, 2013, 18(6): 409-411.
|
| 4. |
趙剛, 程蕾蕾, 裴曉黎, 等. 室壁運動異常患者左室射血分數超聲心動圖檢測方法的選擇. 中國臨床醫學, 2016, 23(3): 299-302.
|
| 5. |
馮婷婷, 賈淑杰, 趙全明. 高密度脂蛋白膽固醇水平與慢性心力衰竭嚴重程度的相關性. 心肺血管病雜志, 2018, 37(8): 735-739.
|
| 6. |
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 2016, 29(4): 277-314.
|
| 7. |
Toyama K, Rader F, Kar S, et al. Iatrogenic atrial septal defect after percutaneous mitral valve repair with the MitraClip system. AmJ Cardiol, 2018, 121(4): 475-479.
|
| 8. |
Katz NM, Hannan RL, Hopkins RA, et al. Cardiac operations in patients aged 70 years and over: mortality, length of stay, and hospital charge. Ann Thorac Surg, 1995, 60(1): 96-100.
|
| 9. |
Agrifoglio M, Trabattoni D, Rossi F, et al. Percutaneous closure of iatrogenic atrial septal defect due to implantation of a left-left "Tandem Heart" ventricle assistance device in a postcardiotomy cardiac failure: six-year follow-up. J Cardiovasc Surg (Torino), 2012, 53(2): 270-272.
|
| 10. |
Losi M, Strisciuglio T, Stabile E, et al. Iatrogenic atrial septal defect (iASD) after MitraClip system delivery: The key role of PaO2/FiO2 ratio in guiding post-procedural iASD closure. Int J Cardiol, 2015, 197: 85-86.
|
| 11. |
Aznaouridis K, Hobson N, Rigg C, et al. Emergency percutaneous closure of an iatrogenic atrial septal defect causing right-to-left shunt and severe refractory hypoxemia after pulmonary vein isolation. JACC Cardiovasc Interv, 2015, 8(11): e179-e181.
|
| 12. |
Rillig A, Meyerfeldt U, Birkemeyer R, et al. Persistent iatrogenic atrial septal defect after pulmonary vein isolation: incidence and clinical implications. J Interv Card Electrophysiol, 2008, 22(3): 177-181.
|
| 13. |
Hammerstingl C, Lickfett L, Jeong KM, et al. Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk?. Am Heart J, 2006, 152(2): 362.e1-362.e5.
|
| 14. |
Rillig A, Meyerfeldt U, Kunze M, et al. Persistent iatrogenic atrial septal defect after a single-puncture, double-transseptal approach for pulmonary vein isolation using a remote robotic navigation system: results from a prospective study. Europace, 2010, 12(3): 331-336.
|
| 15. |
Davies A, Gunaruwan P, Collins N, et al. Persistent iatrogenic atrial septal defects after pulmonary vein isolation: long-term follow-up with contrast transesophageal echocardiography. J Interv Card Electrophysiol, 2017, 48(1): 99-103.
|
| 16. |
吳書林, 廖洪濤, 費洪文, 等. 陣發性心房顫動射頻消融術后左房大小和機械功能變化. 中華心血管病雜志, 2007, 35(2): 127-131.
|
| 17. |
夏曦. 房間隔缺損合并肺動脈高壓患兒導管封堵術后左房結構及功能的變化. 臨床心血管病雜志, 2015, 31(1): 54-56.
|
| 18. |
李靖, 劉延玲, 何青, 等. 正常人群年齡進程中心臟結構和功能的變化特點. 中華心血管病雜志, 2010, 38(1): 52-56.
|
| 19. |
武思雯, 張榮峰, 尹曉盟, 等. 房顫患者術后醫源性房間隔缺損發生情況及影響因素分析. 中國醫藥導報, 2020, 17(11): 44-47.
|
| 20. |
Singh SM, Douglas PS, Reddy VY. The incidence and long-term clinical outcome of iatrogenic atrial septal defects secondary to transseptal catheterization with a 12F transseptal sheath. Circ Arrhythm Electrophysiol, 2011, 4(2): 166-171.
|
| 21. |
Noheria A, Roshan J, Kapa S, et al. Migraine headaches following catheter ablation for atrial fibrillation. J Interv Card Electrophysiol, 2011, 30(3): 227-232.
|